In addition to this new distribution of products, Takara Bio plans to launch contract research services utilizing Exiqon 's products in Japan on December 10, 2012.
MicroRNAs are single-stranded RNAs that are approximately 18 to 26 nucleotides in length, and play key roles in the regulation of gene expression which is essential for living organisms. miRNA research has received a lot of attention in recent years, and has been strongly promoted in the field of cancer research, stem cell research, developmental biology and neuroscience.
Exiqon has its own proprietary LNA™ (Locked Nucleic Acid) technology which makes it unique and puts it well ahead of its competitors. This technology platform offers global miRNA detection or expression profiling with unmatched specificity and sensitivity.
With the addition of Exiqon's competitive products, Takara Bio will continue to offer a comprehensive range of new and innovative products and services which will enhance the convenience of customers.